Crossbow Therapeutics, Inc

Crossbow Therapeutics, Inc

Biotechnology Research

Cambridge, MA 3,616 followers

Established antibody engineering to target the untapped universe of intracellular cancer targets, founded by MPM Capital

Über uns

Crossbow Therapeutics, Inc., is a biotechnology company determined to improve the lives of people with cancer by unlocking the therapeutic potential of T-cell receptor (TCR)-mimetic antibodies. The company’s T-Bolt™ therapies are next-generation, easily assembled immunotherapies directed with high precision at previously unreachable cancer cell targets. Crossbow’s efficient and selective approach is designed to target the entire universe of cancer proteins, dramatically expanding the potential of antibody therapy to address many types of cancer.

Website
http://www.crossbowtx.com
Industrie
Biotechnology Research
Größe des Unternehmens
11-50 Mitarbeiter
Hauptsitz
Cambridge, MA
Typ
In Privatbesitz
Gegründet
2021

Standorte

Employees at Crossbow Therapeutics, Inc

Aktualisierungen

Ähnliche Seiten

Jobs durchsuchen

Finanzierung